Marzo 6, 2024 CLARIS’S PORTFOLIO COMPANIES RECEIVE EASY ACCESS TO EVOTEC’S FULL RANGE OF PRE-CLINICAL AND CLINICAL DEVELOPMENT AND MANUFACTURING CAPABILITIES Hamburg, Germany, and Turin, […] Claris Ventures and Evotec Forge Powerful Partnership to Fast-Track Portfolio Programs Into Clinical Advancement
Febbraio 27, 2023 Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner […] Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner
Gennaio 28, 2023 Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform Sibylla Biotech Raises […] Sibylla Biotech raises €23 Million Series A
Marzo 31, 2022 Iama Therapeutics Raises €8 Million Series A IAMA THERAPEUTICS RACCOGLIE 8 MILIONI DI EURO PER LO SVILUPPO DI UN NUOVO CANDIDATO FARMACO […] Iama therapeutics raises €8 Million Series A
Marzo 24, 2022 Heqet Therapeutics raises €8m to advance its RNA-based therapeutic program for cardiac regeneration March 23rd, 2022 – Heqet Therapeutics, a King’s College London […] Hequet Therapeutics raises €8 million
Marzo 24, 2022 Kither Biotech Raises €18.5 Million Series B Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive […] Kither Biotech Raises €18.5 Million Series B
Luglio 21, 2021 Claris Ventures announces final closing: €85m ($100m) for Italian Biotech Fund oversubscription, one year after its launch by the Turin based SGR […] Claris Biotech I Final Closing
Marzo 9, 2021 NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline Round led by Claris Ventures with 2Invest, 3B Future Health Fund and […] NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline
Settembre 1, 2020 Primo closing a quota €30m per Claris Biotech I, fondo biotech promosso da Claris Ventures SGR Torino, 1 settembre 2020 – Claris […] CLARIS VENTURES LANCIA UN FONDO DEDICATO AL BIOTECH ITALIANO
Aprile 7, 2020 La rivista Prisma dedica un articolo a Claris Ventures La rivista Prisma nel mese di aprile dedica un articolo a Claris Ventures. […] Claris Ventures sulla rivista Prisma di Aprile
Aprile 7, 2020 Covid-19: new report from Claris Ventures on development of drugs and vaccines Claris Ventures pubblished a Vaccines & Treatments Development Snapshot for […] COVID-19: Claris Ventures publishes its report on vaccines and drugs in development
Aprile 7, 2020 Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore Ciro Spedaliere, Managing Partner of Claris […] Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore
Febbraio 14, 2020 Ciro Spedaliere from Claris Ventures in the Life Science Panel of Aifi VentureUp Forum 2020 Ciro Spedaliere, Partner of Claris Ventures, will […] VentureUp Forum 2020
Novembre 16, 2019 Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF) The 39° National Congress of the Italian Pharmacology […] Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF)
